KIFC1 and cancer: Consistent with this model, pharmacological inhibition of KIFC1-S26 phosphorylation specifically induces multipolar cell division and cell death of centrosome-amplified cancer cells via blocking centrosome clustering, thus inhibiting tumor malignant transformation and the rate of recurrence after DNA-damaging therapy.